Modified von Willebrand factor having improved half-life

US11155601B2 · kind B2 · utility

Assignee

• CSL BEHRING LENGNAU AG · CH

Inventors

• Michael Moses · Weilmünster, DE
• Stefan Schulte · Marburg, DE
• Gerhard Dickneite · Marburg, DE
• Uwe Kalina · Marburg, DE
• Sabine Pestel · Biberach, DE
• Thomas Weimer · Gladenbach, DE

Key dates

• Filing date: Mar 4, 2016
• Grant date: Oct 26, 2021
• Expiry date: Nov 25, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to a modified VWF molecule for use in the treatment of a blood coagulation disorder.